CES

Digital

It’s been a decade since I first navigated the dazzling chaos of CES in Las Vegas. The buzz of innovation was thrilling, yet overwhelming.

Views & Analysis

A round-up of this week’s top digital healthcare news. Marco Ricci reports.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.